chanc
effect
chemotherapi
acut
viru
infect
small
acut
infect
viru
multipl
well
advanc
diseas
express
treatment
mani
case
come
late
fenner
white
wecker
control
chemotherapi
might
howev
promis
persist
viru
infect
owe
slow
progress
diseas
suffici
time
treatment
avail
although
variou
way
virus
persist
host
compar
studi
uitro
uiuo
reveal
common
featur
shall
briefli
review
section
includ
low
pathogen
viru
andor
restrict
viru
multipl
variou
cellular
viral
factor
failur
host
defens
elimin
viru
addit
virusinduc
immunopathogen
mechan
consid
respons
patholog
persist
infect
discuss
section
b
anim
model
persist
viru
infect
usual
difficult
experi
vari
length
incub
period
brought
complex
relationship
viru
replic
immun
reaction
diseas
therefor
appear
appropri
studi
activ
antivir
compound
first
persist
infect
cell
cultur
section
v
cultur
prove
use
select
effect
well
toler
antivir
compound
subsequ
studi
uiuo
carri
lymphocyt
choriomening
lcm
viru
section
vi
natur
host
mous
viru
caus
either
acut
persist
toler
infect
hotchin
hotchin
sinc
acut
diseas
adult
mous
caus
direct
virusinduc
injuri
cell
result
immunopatholog
disord
hotchin
diseas
abolish
either
inhibit
viru
multipl
suppress
immun
respons
host
possibl
treatment
consid
cell
type
whether
cytocid
persist
infect
cell
cultur
develop
depend
larg
extent
type
host
cell
use
experi
cell
infect
simian
viru
sv
extens
cell
fusion
subsequ
disintegr
syncytia
occur
small
amount
infecti
viru
releas
contrast
infect
rhesu
monkey
kidney
mk
cell
lead
high
viru
titer
howev
despit
larg
product
infecti
viru
littl
cell
destruct
induc
mk
cell
continu
multipli
almost
unimpair
holm
choppin
mark
differ
interact
variou
type
host
cell
also
describ
newcastl
diseas
ndv
alexand
et
al
hecht
summer
influenza
viru
klenk
et
al
lazarowitz
choppin
failur
host
cell
depend
cleavag
viral
glycoprotein
may
lead
persist
infect
cell
viral
matur
pathogen
form
take
place
holland
levin
b
cell
cycl
viru
multipl
develop
cytopath
effect
cpe
also
depend
stage
cell
cycl
infect
occur
cultur
human
conjunctiva
cell
infect
mump
viru
persist
infect
littl
releas
infecti
viru
develop
cell
kept
growth
medium
transfer
mainten
medium
reduc
serum
content
crowd
cell
cultur
result
howev
increas
viru
titer
walker
hinz
walker
et
al
schwobel
made
similar
observ
cell
infect
sindbi
viru
coloni
deriv
recov
cell
virusinduc
cell
destruct
occur
readili
center
coloni
consist
predominantli
contactinhibit
cell
peripheri
rapidli
divid
cell
domin
contrast
lehmanngrub
observ
pronounc
virusinduc
cpe
lcm
virusinfect
prolifer
mous
fibroblast
compar
rest
cell
c
genet
resist
cell
although
well
establish
resist
cell
line
oncornavirus
genet
control
jolicoeur
role
genet
resist
cell
viruscel
system
less
clear
mani
cell
line
carri
latent
virus
viral
genom
chipmanet
al
weiss
et
al
therefor
persist
infed
cell
often
difficult
discrimin
genet
control
resist
unrespons
due
inappar
viru
infect
develop
increas
resist
due
host
cell
mutant
frequent
observ
cell
cultur
persist
infect
enterovirus
vogt
dulbecco
takemoto
habel
pasca
walker
et
al
howev
experi
virus
eg
paramyxovirus
indic
genet
resist
cell
may
major
factor
control
persist
infect
cell
cultur
rima
martin
interferon
interferon
usual
detect
persist
infect
cell
initi
stage
infect
viruscel
system
character
cyclic
rise
fall
viru
titer
wiktor
clark
show
mammalian
reptilian
cell
infect
rabi
viru
inglot
et
al
sindbi
virusinfect
mous
cell
pattern
rise
fall
level
viral
infect
probabl
mediat
interferon
contrast
interferon
found
hela
cell
human
lung
cell
persist
infect
measl
viru
rustigan
norrbi
cell
line
persist
infect
differ
virus
walker
hinz
fernand
et
al
desmyt
et
al
kawai
et
thu
viruscel
system
interferon
might
import
initi
persist
infect
role
maintain
viru
persist
remain
establish
addit
interferon
virusinduc
regul
viru
multipl
isol
persist
infect
cell
cultur
ter
meulen
martin
temperuturesensit
ts
mutant
frequent
isol
ts
mutant
persist
infect
cell
cultur
observ
increas
viru
product
andlor
virusinduc
cpe
lower
temperatur
norrbi
nagata
et
al
lewandowski
et
al
kimura
et
al
indic
ts
mutant
may
play
import
role
initi
mainten
persist
viral
infect
cell
cultur
howev
littl
known
control
mechan
mediat
ts
mutant
temperaturesensit
mutant
vesicular
stomat
viru
vsv
highli
effect
induc
interferon
nonpermiss
semipermiss
temperatur
sekellick
marcu
sinc
interferon
also
protect
cell
destruct
vsv
sekellick
marcu
suggest
interferon
induc
ts
mutant
may
partial
respons
initi
mainten
vsv
persist
cultur
cell
b
defect
interf
viru
particl
defect
interf
di
viru
particl
found
mani
prepar
dna
rna
virus
character
follow
properti
possess
incomplet
genom
contain
structur
protein
infecti
viru
replic
presenc
helper
viru
interfer
specif
replic
homolog
infecti
viru
huang
baltimor
huang
huang
holland
villar
show
cell
persist
infect
vsv
infecti
viru
free
di
particl
caus
lytic
infect
infect
di
particl
infecti
viru
usual
result
persist
viru
thu
di
particl
obvious
play
role
initi
mainten
persist
infect
cell
cultur
butanalog
ts
mutantsth
molecular
control
mechan
mediat
di
particl
persist
infect
cell
still
obscur
di
particl
vsv
contain
coval
link
complementari
rna
potent
induc
interferon
therefor
might
act
similar
way
ts
mutant
marcu
sekellick
sekellik
marcu
holland
villar
found
depress
translat
activ
cell
coinfect
di
particl
infecti
viru
howev
accord
rima
martin
control
mechan
eg
level
transcript
posttransl
process
viral
protein
consid
c
provir
dna
mechan
viru
persist
zhdanow
et
al
found
virusspecif
dna
sequenc
genom
cell
persist
infect
tickborn
enceph
tbe
viru
addit
infect
tbe
viru
cell
found
persist
infect
oncornaviru
zhdanow
et
al
suggest
longterm
doubleinfect
cell
tbe
oncornaviru
reserv
transcriptas
oncornaviru
transcrib
rna
tumor
viru
also
genom
tbe
viru
integr
cellular
genom
similar
observ
made
cell
infect
either
oncornaviru
measl
viru
zhdanow
parfanovich
oncornaviru
respiratori
syncyti
viru
simpson
iiuma
howev
result
could
confirm
other
friedman
costa
holland
et
al
differ
mechan
appar
exist
initi
mainten
viru
persist
mechan
may
oper
parallel
seri
also
may
chang
cours
infect
schwobel
et
al
studi
cell
persist
infect
sindbi
viru
sever
year
observ
follow
stage
viru
infect
recoveri
gradual
virusinduc
cell
destruct
becom
less
mark
final
disappear
prolong
mainten
although
infecti
viru
releas
cultur
medium
viru
decontamin
cell
less
suscept
reinfect
sindbi
viru
noninfect
control
cell
resist
cell
mutant
might
perhap
respons
chang
viru
suscept
support
find
karyotyp
perman
infect
cell
line
deviat
consider
karyotyp
origin
cell
line
addit
sever
passag
viru
popul
chang
viru
mutant
andor
variant
form
smaller
plaqu
develop
stage
infect
titer
sindbi
virusinfect
cell
line
decreas
gradual
final
prolong
cultiv
infecti
viru
could
detect
appar
virusfre
cell
resist
reinfect
sindbi
viru
experi
persist
infect
cell
line
shown
viru
infect
persist
long
viru
multipl
restrict
small
number
cell
minor
cellular
damag
appear
similar
persist
viru
organ
strohl
schlesing
moreov
experiment
evid
indic
mechan
restrict
viru
multipl
favor
persist
infect
cell
cultur
eg
develop
di
viru
particl
ts
mutant
might
also
respons
initi
mainten
persist
viru
infect
mammal
nih
workshop
popescu
lehmanngrub
friedman
ramseur
howev
addit
control
mechan
common
persist
viru
infect
uitro
uiuo
defens
system
host
play
decis
role
establish
viru
persist
uivo
viru
infect
occur
utero
neonat
time
immun
compet
lack
develop
diseas
often
express
mice
infect
birth
lcm
murin
leukemia
viru
mlv
support
viru
multipl
respond
overt
diseas
first
month
life
evid
exist
toler
cellular
immun
respons
induc
earli
infect
hotchin
huebner
et
al
humor
antibodi
appear
virusantibodi
complex
hirsch
et
al
oldston
dixon
occurr
immun
complex
show
b
cell
respond
presum
tcellindepend
antigen
neonat
infect
virusantibodi
complex
still
infecti
notkin
et
al
hirsch
et
al
porter
et
al
daniel
et
al
infect
target
cell
may
engulf
macrophag
viru
abl
persist
even
replic
way
viru
elimin
macrophag
might
prevent
consequ
viru
persist
initi
moreov
virusinduc
immunodepress
play
import
role
depress
antibodi
respons
observ
infect
experiment
anim
oncornavirus
dent
arenavirus
mim
wainwright
bro
jgrgenson
herpesvirus
osborn
medeari
purchas
et
al
arbovirus
craig
et
al
paramyxovirus
medzon
va
aleutian
mink
diseas
viru
porter
et
al
lodmel
et
al
infecti
agent
slow
viru
diseas
transient
depress
cellular
immun
observ
human
vaccin
live
viru
natur
infect
woodruff
woodruff
clinic
observ
confirm
experiment
data
mice
infect
ndv
gross
leukemia
viru
show
prolong
surviv
allogen
ski
transplant
compar
noninfect
mice
dent
et
al
woodruff
woodruff
follow
mechan
propos
virusmedi
immunosuppress
virusinduc
destruct
function
chang
lymphoid
myeloid
cell
andor
precursor
antigen
competit
immunodepress
result
increas
adrenocort
secret
furthermor
immunodepress
observ
viru
infect
might
partial
mediat
interferon
braun
levi
chester
et
al
johnson
experi
cell
cultur
show
cytotox
reaction
virusinfect
cell
commit
lymphocyt
reduc
abolish
addit
specif
antibodi
phenomena
observ
cell
infect
myxo
paramyxo
oncorna
virus
speel
et
al
porter
howev
signific
block
antibodi
viru
infect
uiuo
remain
establish
insuffici
defens
viral
infect
could
also
caus
modul
viral
antigen
express
cellular
membran
lampert
et
al
observ
cap
strip
viral
antigen
surfac
measl
virusinfect
cell
addit
specif
antibodi
cultur
medium
remov
cellular
antigen
cellular
surfac
occur
rapidli
associ
reduc
antibodymedi
complement
lysi
cell
strip
cell
howev
continu
synthes
express
viral
antigen
could
detect
cytoplasm
regard
elev
antibodi
titer
measl
viru
patient
subacut
scleros
panenceph
sspe
suggest
antigen
modul
observ
vitro
may
play
central
role
pathogenesi
sspe
persist
viru
infect
hightit
antibodi
respons
function
defici
immun
system
observ
neonat
viru
infect
appar
includ
also
reduc
product
andor
respons
interferon
experi
coxsacki
viru
henneberg
et
al
adult
mice
produc
interferon
tissu
infect
suckl
mice
produc
small
amount
interferon
liver
similar
result
obtain
baron
isaac
inject
four
differ
virus
chicken
differ
age
group
virus
tend
caus
persist
infect
usual
potent
induc
interferon
natur
host
instanc
varicella
zoster
cytomegaloviru
induc
littl
interferon
human
cell
line
virus
also
resist
interferon
glasgow
et
al
armstrong
merigan
interferon
found
mice
persist
infect
lcm
viru
howev
infect
mice
respond
virus
format
interferon
mim
subrahmanyan
thu
inabl
produc
interferon
appar
restrict
viru
caus
persist
infect
virus
induc
persist
infect
usual
sever
destruct
effect
cell
caus
minim
chang
cell
metabol
valid
bud
virus
long
incub
period
howev
cytolyt
virus
may
also
caus
persist
infect
virusinduc
cell
destruct
restrict
rel
small
number
cell
whose
loss
sever
affect
organ
fenner
et
al
among
factor
limit
viru
multipl
induc
persist
infect
di
viru
particl
ts
mutant
seem
play
import
role
huang
accord
huang
baltimor
follow
virushost
interact
may
take
place
condit
di
viru
produc
host
cell
infect
standard
infecti
viru
particl
produc
infecti
viru
transmit
cell
new
cycl
viru
replic
follow
final
result
acut
ill
cell
infect
di
particl
produc
progeni
howev
simultan
infect
standard
viru
di
particl
take
place
infecti
viru
function
helper
viru
type
particl
produc
replic
howev
limit
interfer
time
equilibrium
reach
format
infecti
viru
di
particl
permit
continu
viru
replic
rel
low
rate
littl
appar
damag
organ
interact
might
relev
initi
mainten
persist
viru
infect
welsh
popescu
lehmanngrub
addit
di
viru
particl
ts
viru
mutant
may
regul
viru
replic
thu
determin
cours
infect
field
infect
newborn
rat
either
wildtyp
ts
mutant
reoviru
type
found
anim
infect
wildtyp
viru
die
acut
enceph
within
week
wherea
ts
mutant
caus
fatal
enceph
administr
high
viru
concentr
lower
concentr
major
anim
surviv
infect
appear
clinic
heal
thi
howev
sever
week
month
later
histolog
examin
reveal
degener
cerebr
cortex
secondari
enlarg
cerebr
ventricul
chang
neurovirul
also
observ
mice
infect
ts
mutant
measl
vesicular
stomat
virus
haspel
rapp
stanner
goldberg
sign
symptom
viru
infect
emerg
primarili
cell
destruct
either
caus
directli
viru
mediat
immun
mechan
virusspecif
immun
reaction
may
trigger
effector
amplif
mechan
eg
complement
system
result
local
inflammatori
process
system
disturb
follow
possibl
interact
viru
host
defens
deriv
experiment
clinic
investig
allison
et
al
b
antibodymedi
cytotox
viru
replic
accompani
express
new
antigen
cell
surfac
antibodi
complement
may
interact
virusinduc
cellular
surfac
antigen
virusinfect
cell
destroy
innoc
bystand
consequ
virusspecif
immun
reaction
coomb
gell
shown
cell
infect
herp
simplex
vaccinia
influenza
newcastl
diseas
virus
brier
et
al
passiv
administr
viral
antibodi
anim
infect
respiratori
syncyti
japanes
b
enceph
aleutian
mink
diseas
viru
produc
intensifi
viral
lesion
allison
et
al
indic
antibodymedi
cytotox
play
role
pathogenesi
viral
infect
b
format
immun
complex
persist
viru
infect
high
output
viral
antigen
may
lead
virusantibodi
complex
deposit
solubl
immun
complex
usual
phagocytoz
circul
macrophag
howev
amount
immun
complex
exhaust
phagocytoz
capac
macrophag
system
immun
complex
precipit
preferenti
site
eg
glomeruli
activ
complement
immun
complex
polymorphonuclear
leukocyt
attract
subsequ
phagocytosi
immun
complex
releas
lysosom
enzym
mediat
acut
inflammatori
reaction
inflammatori
reaction
increas
caus
tissu
injuri
depend
site
virusantibodi
complex
deposit
immun
complex
diseas
glomerulonephr
vascul
arter
arthriti
may
develop
instanc
glomerulonephr
observ
mice
persist
infect
lcm
viru
patient
hepat
b
almeida
waterson
oldston
dixon
cellmedi
cytotox
lymphocyt
recogn
virusinduc
antigen
present
cell
surfac
follow
blastogenesi
gener
lymphokin
destruct
infect
cell
result
chronic
inflammatori
respons
character
accumul
mononuclear
cell
cellular
immun
reaction
play
decis
role
develop
virusinduc
exanthema
observ
infect
measl
rubella
canin
distemp
viru
delay
hypersensit
reaction
skin
caus
poxvirus
allison
et
al
howev
best
exampl
virusinduc
cellular
immunopathogen
mechan
lmc
viru
infect
mous
lead
adult
mice
lethal
choriomening
within
day
wherea
neonat
mice
persist
toler
infect
develop
hotchin
depress
humor
andor
cellular
immun
reaction
observ
infect
mammal
varieti
rna
dna
virus
discuss
section
iii
l
viral
gene
somat
cell
may
lead
emerg
neoantigen
either
viruscod
virusinduc
hostcod
moreov
complex
consist
viruscod
virusinduc
normal
cell
surfac
antigen
may
result
new
antigen
determin
overlap
specif
consequ
complex
antigen
may
lead
autoimmun
process
involv
noninfect
cell
distant
site
crossreact
normal
noncomplex
cell
surfac
antigen
anoth
possibl
virusinduc
immunopathogen
mechan
may
deriv
loss
normal
cell
surfac
antigen
might
result
express
cryptantigen
normal
access
antibodi
commit
lymphocyt
therefor
may
recogn
foreign
addit
neoantigen
may
shed
infect
cell
induc
system
immunopatholog
reaction
either
mimic
autoimmun
process
persist
viru
infect
immun
mechan
play
decis
role
express
diseas
two
possibl
approach
chemotherapi
consid
modul
ie
suppress
immun
respons
abolish
antigen
stimulu
inhibit
viru
multipl
product
viral
compon
sign
symptom
certain
chronic
viru
infect
eg
lcm
chronic
diseas
promin
immunopatholog
process
possibl
viru
etiolog
eg
system
lupu
erythematosu
rheumatoid
arthriti
greatli
reduc
immunosuppress
howev
immunosuppress
treatment
appli
limit
period
furthermor
latent
virus
eg
herp
simplex
herp
mster
cytomegalo
oncornavirus
might
activ
risk
infect
nonvir
agent
consider
increas
therefor
inhibit
viru
multipl
antivir
agent
appear
promis
approach
control
major
chronic
viru
diseas
immunosuppress
treatment
similar
chemotherapi
bacteri
fungal
infect
viru
replic
inhibit
antivir
compound
level
immun
system
abl
elimin
residu
viru
howev
often
uncertain
whether
immun
system
realli
elimin
viru
organ
acut
appar
nonappar
infect
follow
intraperiton
infect
adult
mice
lcm
viru
mild
diseas
uncharacterist
symptom
develop
last
week
haa
mice
recov
lcm
viru
rare
isol
appar
healthi
mice
treat
antilymphocyt
serum
viremia
develop
high
viru
titer
volkert
lundstedt
thu
lcm
viru
still
present
sever
week
recoveri
host
observ
varicella
measl
mump
sever
enceph
virus
may
induc
lifelong
immun
organ
indic
varieti
virus
may
persist
host
acut
appar
nonappar
infect
viru
replic
obvious
reduc
minimum
host
defens
system
equilibrium
infecti
agent
host
establish
clinic
nonappar
equilibrium
disturb
occurr
defici
immun
system
viru
start
replic
high
rate
viru
multipl
lead
acut
low
rate
predominantli
chronic
diseas
object
viru
chemotherapi
would
therefor
restor
equilibrium
viru
defens
mechan
host
rather
therapiu
magna
sterilan
antivir
agent
defin
substanc
inhibit
viru
replic
thu
cure
reduc
sign
diseas
virusinfect
host
becker
substanc
possess
cytotox
cytostat
immunosuppress
activ
effect
concentr
compound
watersolubl
reach
target
organ
requir
concentr
chemotherapeut
index
ratio
highest
nontox
lowest
effect
concentr
high
uitro
uiuo
antivir
agent
possess
mutagen
activ
ie
occurr
resist
mutant
treatment
exceed
natur
mutat
rate
effect
compound
virusspecif
follow
mode
action
envisag
inhibit
viru
attach
penetr
uncoat
viral
nucleic
acid
synthesi
viral
translat
virusspecif
posttransl
cleavag
protein
viru
matur
inhibitor
viru
attach
penetr
uncoat
prevent
viru
infect
cell
thu
inhibit
spread
viru
within
host
sinc
inhibitor
interfer
earli
phase
replic
cycl
appear
suitabl
prophylact
treatment
inhibitor
viral
nucleic
acid
synthesi
eg
antimetabolit
incorpor
viral
dna
often
mutagen
prusoff
ward
compound
also
inhibit
dna
synthesi
divid
cell
use
chemotherapi
limit
better
chanc
success
chemotherapi
might
howev
provid
compound
activ
virusinduc
enzym
chen
et
al
compound
specif
inhibit
viruscod
enzym
requir
viru
synthesi
overbi
et
al
helgstrand
oberg
search
antivir
compound
usual
carri
cell
cultur
inhibit
viral
cpe
viru
plaqu
format
suppress
virusinduc
inhibit
cell
metabol
use
indic
antivir
activ
salk
et
al
rada
zawada
schwobel
howev
cell
cultur
test
often
difficult
discrimin
effect
cellular
process
specif
antivir
effect
therefor
test
persist
infect
cell
cultur
establish
provid
precis
inform
antivir
cytotox
activ
compound
usual
cell
cultur
screen
test
base
acut
infect
cell
schwobel
streissl
b
persist
infect
initi
variou
cell
line
differ
respect
growth
characterist
viru
u
suscept
infect
cell
subcultur
variou
interv
supplement
new
medium
rate
viru
cell
multipl
permit
continu
cultiv
cell
viral
antibodi
inhibitor
viru
multipl
use
establish
persist
infect
howev
one
sublin
use
experi
vaccinia
viru
previous
infect
sindbi
viru
sindbi
virusinfect
cell
subcultur
four
year
viru
seem
disappear
cell
line
differ
virus
destroy
cell
origin
line
complet
caus
without
adapt
persist
infect
sublin
schwobel
streissl
assay
antivir
activ
carri
accord
follow
scheme
fig
low
concentr
iudr
fig
reduc
titer
vaccinia
plaqu
reduct
pr
test
herrmann
persist
infect
cell
tabl
picc
test
howev
cytotox
effect
occur
pgml
wherea
pr
test
effect
detect
pgml
virusinduc
therapyinduc
cytotox
effect
could
easili
distinguish
differ
morpholog
fig
increas
plaqu
number
day
treatment
may
indic
develop
drugresist
mutant
variant
optim
concentr
iudr
treatment
persist
infect
cell
appear
pgml
sinc
neither
virusinduc
cpe
drugrel
cytotox
effect
occur
day
treatment
confluenc
cell
layer
increas
remain
unchang
observ
period
day
howev
even
optim
concentr
cultur
could
cure
infect
infecti
viru
could
alway
isol
cultur
medium
schwobel
streissl
persist
infect
cell
cultur
character
cyclic
rise
fall
viru
titer
due
period
fluctuat
virusinduc
cell
destruct
cell
recoveri
consequ
oscil
viru
titer
result
obtain
treat
untreat
cultur
differ
variou
time
mainli
observ
low
concentr
test
compound
instanc
pgml
iudr
reduc
number
viru
plaqu
first
day
treatment
tabl
howev
due
pronounc
decreas
viru
titer
control
day
plaqu
number
treat
cultur
higher
control
therefor
import
evalu
antivir
compound
picc
test
compar
treat
untreat
cultur
period
sever
day
treatment
cell
persist
infect
fmd
viru
type
c
variou
concentr
bisbenzimidazol
deriv
fig
increas
releas
infecti
viru
cultur
medium
observ
increas
activ
found
pr
test
greater
releas
fmd
viru
occur
lower
pgml
higher
concentr
pgml
test
compound
effect
associ
higher
concentr
cytotox
activ
observ
cell
cultur
calf
serum
nutrient
medium
lower
concentr
serum
permit
stimul
similar
result
obtain
fmd
viru
subtyp
schwobel
streissl
therefor
contrast
pr
test
inhibitori
activ
recogn
picc
test
also
suit
detect
stimulatori
effect
chemic
compound
viru
multipl
import
view
possibl
activ
latent
viru
infect
antivir
compound
experi
confluenc
monolay
rel
avail
surfac
area
day
start
experi
use
criterium
antivir
activ
test
compound
period
infect
cell
subcultur
three
time
fpa
fig
least
effect
exhibit
cytotox
effect
heparin
activ
well
toler
cell
iudr
etudr
fig
iv
show
pronounc
antivir
effect
rel
low
concentr
pgml
cytotox
effect
observ
iudr
etudr
pgml
respect
infecti
viru
present
cultur
also
protect
virusinduc
cell
destruct
schwobel
streissl
although
singl
antivir
compound
caus
signific
decreas
viru
titer
loss
virusinduc
cpe
persist
infect
cell
cure
cell
infect
never
observ
contrast
complet
decontamin
hsvinfect
cell
achiev
use
combin
antivir
compound
heparin
iudr
heparin
iudr
differ
mechan
action
iudr
incorpor
viral
dna
place
thymidin
thu
prevent
new
synthesi
viral
dna
prusoff
et
al
heparin
inhibit
viral
attach
cell
membran
hochberg
becker
also
caus
releas
virion
alreadi
adsorb
cell
nahmia
kibrick
compound
inhibit
significantli
replic
hsv
cell
cultur
howev
antivir
activ
could
increas
combin
applic
compound
hsvinfect
cell
cultur
treat
celltoler
concentr
pglml
heparin
pgml
iudr
infecti
viru
found
cell
remain
virusfre
eight
subcultiv
nutrient
medium
without
test
compound
show
picc
test
permit
differenti
compound
cure
cell
cultur
viru
infect
compound
temporarili
retard
viru
product
schwobel
streissl
emerg
drugresist
viru
mutant
variant
describ
major
antivir
agent
reni
buthala
herrmann
herrmann
format
drugresist
viru
mutant
therefor
consid
evalu
antivir
drug
develop
therapi
resist
easili
studi
persist
infect
cell
cultur
cell
persist
infect
hsv
cultiv
day
presenc
pgml
etudr
highest
concentr
etudr
viru
replic
untreat
viru
batch
serv
control
suscept
untreat
etudrpretr
viru
popul
antivir
action
etudr
compar
use
pr
test
result
shown
fig
untreat
viru
popul
concentr
test
compound
plaqu
number
reduc
ed
pgml
viru
cultiv
presenc
etudr
howev
greater
pgml
experi
iudr
herrmann
phosphonoacet
acid
fig
v
mao
et
al
trifluorothymidin
fig
vi
kaufman
heidelberg
etudrresist
viru
crossresist
iudr
phosphonoacet
acid
etudrresist
viru
howev
sensit
trifluorothymidin
wildtyp
viru
way
combin
antivir
drug
found
much
effect
singl
drug
schwobel
et
al
b
efficaci
compound
depend
antivir
activ
lack
cytotox
also
biovail
drug
target
organ
egger
therefor
subsequ
detect
antivir
activ
compound
cell
cultur
assay
experi
anim
done
howev
mani
virus
requir
extens
adapt
laboratori
anim
result
obtain
test
may
applic
origin
host
sinc
cours
diseas
laboratori
anim
may
quit
differ
bucknal
moreov
virus
eg
human
rhinoand
coronavirus
suitabl
anim
test
avail
therefor
select
studi
lcm
viru
natur
host
mous
viru
caus
host
either
acut
persist
toler
infect
fatal
choriomening
develop
intracerebr
inject
lcm
viru
immunocompet
mice
experiment
evid
indic
acut
lcm
mediat
commit
lymphocyt
abl
lyse
host
cell
carri
viral
antigen
cellular
membran
hotchin
follow
viru
inject
foot
pad
mice
mark
edemat
swell
observ
local
swell
may
extend
gross
edema
whole
leg
last
approxim
week
usual
follow
complet
recoveri
disord
probabl
repres
immunopathogen
event
hotchin
hotchin
benson
lifelong
persist
infect
appar
sign
diseas
earli
phase
either
induc
congenit
neonat
infect
viru
inocul
otherwis
immunoincompet
mice
later
life
howev
persist
infect
mice
may
develop
glomerulonephr
elicit
viru
antigenantibodi
complex
oldston
dixon
differ
form
diseas
induc
lcm
viru
use
studi
effect
select
antivir
compound
lcm
viru
multipl
express
diseas
although
amantadin
hydrochlorid
fig
vii
reduc
number
lcm
viru
plaqu
cell
cultur
effect
either
acut
persist
viru
infect
observ
mous
tabl
heteropolyanion
ammonium
pentatungstodiantimon
fig
viii
caus
increas
surviv
rate
mice
intracerebr
infect
lcm
viru
howev
compound
reduc
viru
titer
blood
persist
infect
mice
lasparaginas
also
inact
persist
infect
compound
delay
prevent
diseas
immunosuppress
appli
day
intracerebr
infect
streissl
sinc
none
antivir
compound
activ
persist
infect
lcm
viru
isol
persist
infect
mice
effect
amantadin
hydrochlorid
ammonium
pentatungstodiantimon
viru
isol
test
pr
test
titer
viru
isol
persist
infect
mice
reveal
differ
sensit
antivir
drug
compar
standard
viru
foot
pad
respons
ammonium
pentatungstodiantimon
inact
intraven
well
intramuscular
applic
streissl
contrast
lasparaginas
caus
signific
reduct
paw
swell
fig
swell
start
untreat
control
day
reach
peak
day
pi
intramuscular
inject
iu
lasparaginas
site
infect
hour
hour
infect
swell
notic
day
pi
howev
day
treatment
termin
weak
swell
depend
concentr
viru
inoculum
occur
effect
lasparaginas
foot
pad
respons
dosedepend
also
observ
intraven
treatment
activ
lasparaginas
observ
acut
intracerebr
infect
foot
pad
respons
obvious
caus
immunosuppress
activ
maral
et
al
sinc
antivir
effect
recogn
either
cell
cultur
test
persist
infect
mice
mode
action
ammonium
pentatungstodiantimon
remain
howev
obscur
addit
antivir
activ
compound
possess
cytotox
possibl
im
munosuppress
activ
jasmin
et
al
effect
acut
lcm
may
therefor
relat
antivir
perhap
immunosuppress
effect
could
also
act
synergist
result
werner
et
al
interest
respect
sinc
show
emc
virusinfect
mice
could
protect
ammonium
pentatungstodiantimon
lethal
encephalomyel
despit
fact
treat
mice
conpar
viru
titer
blood
brain
untreat
control
observ
none
compound
inhibit
lcm
viru
multipl
persist
infect
mice
conclus
interpret
seem
unlik
chang
viru
respons
neg
result
sinc
viru
isol
persist
infect
mice
uitro
equal
suscept
treatment
ammonium
pentatungstodiantimon
standard
viru
rather
appear
persist
lcm
viru
infect
well
establish
mous
even
compound
activ
test
model
reduct
viru
product
could
achiev
cell
persist
infect
hsv
could
cure
viru
infect
cell
treat
two
differ
antivir
compound
combin
treatment
two
effect
well
toler
antivir
compound
might
also
requir
reduc
lcm
viru
replic
persist
infect
mice
picc
test
appear
well
suit
find
character
compound
viru
chemotherapi
littl
success
far
clinic
effect
antivir
drug
avail
bauer
mainli
due
fact
virus
obligatori
intracellular
parasit
complet
depend
metabol
cell
replic
viru
infect
cell
new
entiti
viruscel
complex
form
complex
viru
multipl
cell
metabol
intim
link
inhibit
viru
multipl
without
injuri
host
cell
difficult
achiev
whitley
alford
howev
anoth
reason
failur
chemotherapi
acut
viru
infect
due
fact
viru
product
usual
reach
maximum
symptom
appear
treatment
initi
time
contrast
time
therapi
play
crucial
role
persist
viru
infect
persist
infect
establish
uitro
uiuo
virus
might
caus
chronic
diseas
human
aid
picc
test
compound
highli
effect
virus
select
subsequ
test
possibl
use
antivir
drug
suitabl
model
uiuo
appear
experiment
approach
provid
better
chanc
success
search
antivir
compound
success
chemotherapi
investig
base
acut
viru
infect
